Search Results

Containing any of the words

Only of the type

SFDA: 83% Growth in Clinical Research for Biotechnology Products in 2025 News

What does mean, “The timeframe for returned MDMA application is 60 calendar days” in announcement (8) 8/2019? FAQ

(SG-1902-11-H) Potential risks associated with using of ARCUS treatment table manufactured before 2009 by FREI AG Medical Report

Disclosure and Undertaking Form for Requesting Permission to Import Products for General Laboratory Use Forms

International collaborative treatment protocol for infants under one year with KMT2Arearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia (Interfant-21) Drug Clinical Trial

The SFDA Grants Breakthrough Designation to "Itovebi" for Advanced Hormone Resistant Breast Cancer Treatment News

Stronger Heart Failure Risk Warnings for the Diabetes Drugs Rosiglitazone (Avandia) and Pioglitazone (Actos) Warnings

SFDA: Healthy and Balanced Meals Improve Students’ Performance and Boost their Energy News

"A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA in the Prevention of Stroke and Death in Patients with Acute Ischaemic Stroke or Transient Ischaemic Attack[THALES - Acute STroke or Transient IscHaemic Attack Treated with TicAgreLor and ASA for PrEvention of Stroke and Death]" Drug Clinical Trial

Is it required to provide a risk assessment form with each Field Safety Corrective Action? FAQ